Photo: National Cancer Institute / Unsplash

Saham onkologi kapitalisasi rendah: Perusahaan kecil yang bertarung dengan kanker

17 simbolDiupdate

As knowledge of what causes and helps prevent cancer develops, so does the expertise on how to tackle it face-on. Today, oncology represents one of the world’s fastest-moving therapeutic areas, set to represent more than a quarter of pharmaceutical sales by 2022. Part of this growth has been facilitated by the emergence of smaller companies taking innovative and novel approaches to the clinical practices such as T-cell treatments and precision medicines.

This Spark contains some of these smaller firms involved in cancer research or treatment in the US, with a market cap of less than 300m. For bigger companies, we have you covered with major firms or mid-cap firms. But don't rely on these lists alone. This isn't advice, so make sure you do your own research.

Berita

Tidak ada berita hari ini

Tidak ada informasi tentang peristiwa dunia yang terbaru